Cordinamo is established and privately owned by Diny Amo-Reneman. Diny has started her career at an international well-known Core Laboratory in Rotterdam. During her in-depth training by renowned cardiologists of the Erasmus Medical Center and the close co-operation with both national and international cardiologists, she has conquered an important position in the world of interventional cardiology.
Throughout her career at two Core Laboratories in the Netherlands, she has gained extensive experience in the development and implementation of quantitative and qualitative coronary analyses.
Her dedication to deliver the very highest quality of data, in combination with many years of experience in clinical trials, has conducted to the inception of Cordinamo.

Cordinamo participated in following trials:

In-vivo systemic evaluation of early stent healing (coverage around first month). OCT analyses and morphological classification of stent struts. 

Multi-center, randomized trial to study the impact of percutaneous coronary intervention on left ventricular function in patients with a non-infarct related chronic total occlusion after ST-elevation myocardial infarction: PCI vs. conservative approach in CTO patients after STEMI. On site monitoring. 

Drug eluting bAlloon for in-stent REstenosis.

Preventing Restenosis of Cerebral Arterial Stents with Aggrenox, Prof. dr. dr. Wolfgang Eisert. 

Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study
Related article in The New England Journal of Medecine: http://content.nejm.org/cgi/content/full/358/6/557

Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth.

Ongoing Tirofiban In Myocardial infarction Evaluation.

Epicardial and Microvascular Flow improvement in patients with Acute Myocardial Infarction undergoing either conventional PCI or a strategy of additional aspiration using the Medtronic EXportTM catheter system: A PrOspective, Randomized, Controlled Study.

TRIOS Clinical Trial
Clinical evaluation to assess the safety and effectiveness of Trios, the paclitaxel eluting R Stent, in diseased de novo coronary arteries, compared to concurrent non-coated R Stent Evolution 2 controls.

Direct stenting: does it reduce restenosis? Angioplasty with optional stent implantation compared with direct stenting without predilatation.

Early or Late Intervention in unStable Angina.

Early or Late Intervention in high risk non ST-elevation Acute Coronary Syndromes.